Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

417 projects found matching your search criteria :

  1. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

  2. Analysis of the effects of proteotoxic stress on cholesterol homeostasis and its associations with cardiovascular diseas...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Wiesława Elżbieta Widłak

    Narodowy lnstytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy lnstytut Badawczy

  3. Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap...

    Call: OPUS 28 , Panel: NZ3

    Principal investigator: prof. Jarosław Piotr Czyż

    Uniwersytet Jagielloński

  4. Biomaterial enriched with propolis extract as a promising chemopreventive dressing material after melanoma excision

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Marta Trzaskowska

    Uniwersytet Medyczny w Lublinie

  5. Cellular effects in the tumor microenvironment and the potential for targeted delivery of molecules associated with the ...

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: prof. Magdalena Maria Staniszewska

    Katolicki Uniwersytet Lubelski Jana Pawła II

  6. N6-methyladenine metabolism - potential relationships with the development of hematological malignancies.

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Marta Starczak

    Uniwersytet Mikołaja Kopernika w Toruniu

  7. Frog skin derived cyclic peptide as a molecular scaffold to create a novel tool for combining visualization and inhibiti...

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: Aleksandra Dorota Helbik-Maciejewska

    Uniwersytet Gdański

  8. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

  9. Identification of novel microRNA biomarkers in liquid biopsy of patients with neuroendocrine tumors

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Paweł Mateusz Komarnicki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  10. (Lipid-FLUX) Single-cell lipidomics by spectroscopy: Quantification of the lipid transport through the development of ne...

    Call: OPUS 27 , Panel: ST4

    Principal investigator: prof. Małgorzata Anna Barańska

    Uniwersytet Jagielloński

  11. Innovative Small Molecule Inhibitors Targeting LAG-3 and MHCII Complex for Tumour Immunotherapy

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

  12. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Dominik Jakub Dreszer

    Uniwersytet Śląski w Katowicach

  13. Neutrophil-targeted immune response as an effective approach in immunotherapyof gastrointestinal cancers

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Damian Jacenik

    Uniwersytet Łódzki

  14. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

  15. Controlling the covalent activity of a PD-L1 inhibitors with light

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Wiktor Jan Uzar

    Uniwersytet Jagielloński

  16. EGR1 Protein: A Key Factor in Cellular Homeostasis?

    Call: PRELUDIUM 23 , Panel: NZ3

    Principal investigator: Marta Leśniczak-Staszak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  17. The two are better than one - biferrocenyl ROS generators as intelligent anticancer agents

    Call: OPUS 27 , Panel: ST5

    Principal investigator: prof. Konrad Maciej Kowalski

    Uniwersytet Łódzki

  18. Interrogation of the antigen presentation dynamics via MHCII in tumor immune evasion through multimodal single-cell sequ...

    Call: SONATINA 8 , Panel: NZ2

    Principal investigator: dr Natalia Ochocka-Lewicka

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  19. Design, synthesis and biological evaluation of Steroid Sulfatase Inhibitors based on organophosphorus compounds.

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr Sebastian Demkowicz

    Politechnika Gdańska

  20. CAR(dio)-T(oxicity)- Engineered Heart Tissue model for CAR-T cardiotoxicity evaluation

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Agnieszka Joanna Zimna

    Instytut Genetyki Człowieka Polskiej Akademii Nauk

  21. Computational methods for understanding tumor immune microenvironment from spatial imaging data

    Call: SONATA 19 , Panel: NZ2

    Principal investigator: dr Krzysztof Kamil Gogolewski

    Uniwersytet Warszawski, Wydział Matematyki, Informatyki i Mechaniki

  22. Tumor viscoelasticity as a central player in glioblastoma treatment - towards mechanopharmacology

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Pogoda

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego Polskiej Akademii Nauk

  23. To be or not to be modified: the role of single m6A sites of long noncoding RNAs in breast cancer

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Elżbieta Wanowska

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  24. Organometallic (Fe, Ru, Ir, Os) phospho-inducers of drug-resistant cancer cells' ferroptosis

    Call: OPUS 26 , Panel: ST4

    Principal investigator: dr hab. Urszula Katarzyna Komarnicka

    Uniwersytet Wrocławski, Wydział Chemii

  25. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  26. Exploring the influence of genomic features on mutational signatures across tumors

    Call: OPUS 26 , Panel: NZ2

    Principal investigator: dr Damian Michał Wójtowicz

    Uniwersytet Warszawski, Wydział Matematyki, Informatyki i Mechaniki

  27. Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Danuta Dudzik

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  28. Design and characterisation of sealing materials of prosthetic obturator being additionally a cytostatic drug reservoir....

    Call: OPUS 26 , Panel: ST8

    Principal investigator: prof. Anna Trusek

    Politechnika Wrocławska

  29. Functional and structural analysis of anticancer drugs as protein biosynthesis inhibitors

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Witold Szaflarski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  30. Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

    Call: SONATA BIS 13 , Panel: NZ7

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  31. Searching for novel regulators of antitumor immune response

    Call: MAESTRO 15 , Panel: NZ6

    Principal investigator: dr hab. Magdalena Hanna Winiarska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  32. XAICancer: Explainable Artificial Intelligence for Cancer Imaging

    Call: SONATA BIS 13 , Panel: ST6

    Principal investigator: dr Neo Christopher Chung

    Uniwersytet Warszawski, Wydział Matematyki, Informatyki i Mechaniki

  33. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  34. Development of novel bifunctional ceramic coatings with osteoinductive and anti-oncogenic properties on metallic implant...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Balbina Karina Makurat-Kasprolewicz

    Politechnika Gdańska

  35. Multifunctional emulsion-based transporters for personalised cancer treatment

    Call: OPUS 25 , Panel: ST8

    Principal investigator: prof. Ewa Dłuska

    Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

  36. Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  37. Efficiency biomarkers in photodynamic therapy against lung cancer

    Call: PRELUDIUM 2 , Panel: NZ4

    Principal investigator: dr Martyna Krzykawska-Serda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  38. The study of the effect of hypoxia on the metabolism of exogenous ferritin and its role in the regulation of free iron i...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: dr Małgorzata Maria Kubiak

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Centrum Immunoterapii Komórkowych

  39. The design and development of the peptide inhibitors library targeting Zn(II)-binding site of matrix metalloproteinases ...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Paulina Alicja Potok

    Uniwersytet Wrocławski, Wydział Chemii

  40. Molecular profiling of soft tissue sarcomas in tumor and peripheral blood in terms of response to treatment and early de...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Piotr Łukasz Rutkowski

    Narodowy lnstytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy lnstytut Badawczy

  41. Are bisphenol S and F safe substitutes for bisphenol A in the face of environmental contamination with estrogenic mycoto...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Justyna Kozieł

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  42. Myeloid cell subpopulations as a source of effector cells for anticancer therapies using CAR chimeric receptors

    Call: OPUS 25 , Panel: NZ6

    Principal investigator: dr hab. Angelika Muchowicz

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  43. Targeting undruggable proteins involved in tumorigenesis – developing and characterization of advanced nanoplatform for ...

    Call: OPUS 25 , Panel: NZ6

    Principal investigator: dr hab. Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Bitechnologii

  44. 3D-printed bone implants - Exploring the relationship between the chemical and spatial structure of implants and their s...

    Call: OPUS 25 , Panel: ST4

    Principal investigator: prof. Edyta Proniewicz

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Odlewnictwa

  45. Spatial Determinants of Immunotherapy Resistance in Cancer

    Call: WEAVE-UNISONO , Panel: NZ6

    Principal investigator: dr Marcin Tabaka

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  46. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  47. Dissecting the regulatory interplay between proteases and protein kinases in acute lymphoblastic leukemia using mass cyt...

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  48. Identifying angiogenic and metabolic biomarkers in endometriosis-associated ovarian cancer using photoacoustic imaging a...

    Call: POLONEZ BIS 3 , Panel: NZ5

    Principal investigator: dr Monika Anna Golińska

    Uniwersytet Medyczny w Łodzi

  49. Evaluation of anti-neoplastic activity of LAB-derived postbiotics as a potential tool to support standard chemotherapy i...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Janusz Zbigniew Szemraj

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

  50. Functional analysis of monocyte chemoattractant protein-induced protein (MCPIP) in human neuroblastoma cells

    Call: OPUS 2 , Panel: NZ1

    Principal investigator: prof. Hanna Barbara Rokita

    Uniwersytet Jagielloński

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy